Clopidogrel bisulfate form 1 from different salts of clopidogrel

• 1. 硫酸氢氯吡格雷组合物、硫酸氢氯吡格雷片剂及其制备方法 [P] . 中国专利： CN109528669A . 2019-03-29
• 2. 一种Ⅰ型硫酸氢氯吡格雷颗粒及其制备方法和Ⅰ型硫酸氢氯吡格雷固体制剂的制备方法 [P] . 中国专利： CN104490874B . 2017.09.29
• 3. A PROCESS FOR RACEMIZATION OF (R) CLOPIDOGREL AND PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM I [P] . IN298203B . 2018-07-06

  机译： （R）脂磷脂的再定型过程和脂硫酸氢盐形式I的制备方法

• 4. A PROCESS FOR RACEMIZATION OF (R) CLOPIDOGREL AND PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM I [P] . IN298203B . 2018-06-28

  机译： （R）脂磷脂的再定型过程和脂硫酸氢盐形式I的制备方法

• 5. A PROCESS FOR RACEMIZATION OF (R) CLOPIDOGREL AND PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM I [P] . IN2009KO01373A . 2013-06-28

  机译： （R）脂磷脂的再定型过程和脂硫酸氢盐形式I的制备方法

• 1. A meta-analysis of the safety of clopidogrel and tegrarol in patients with non-ST elevation acute coronary syndrome after PCI in China [J] . Xiao-Min Gao, Bin Hu, Du-Xia Liu, 海南医科大学学报（英文版） . 2020,第015期
• 2. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects. [J] . Kim SD, Kang W, Lee HW, Clinical therapeutics . 2009,第4期
• 3. Simultaneous estimation of acetylsalicylic acid and clopidogrel bisulfate in pure powder and tablet formulations by high-performance column liquid chromatography and high-performance thin-layer chromatography [J] . Patel Rashmin B., Shankar Madhira B., Patel Mrunali R., Journal of AOAC International . 2008,第4期
• 4. Formulation and in-vivo evaluation of modified dosage form of Clopidogrel bisulfate [J] . Sunil Kumar Panda, Subas Chandra Dinda American Journal of PharmTech Research . 2014,第2期
• 5. Study on the Process of Reactive Crystallization of Clopidogrel Bisulfate [C] . Song Liangcheng, Wang Jingkang, Gong Junbo Proceedings of international symposium on crystal engineering and drug delivery system 2009 . 2009
• 6. The Comparative Effectiveness, Safety, Value, and Adherence of Newer P2Y12 Inhibitors versus Clopidogrel in the Context of Heterogeneity [D] . Suh, Kangho. 2019
• 7. Influence of Microenvironment pH Humidity and Temperature on the Stability of Polymorphic and Amorphous Forms of Clopidogrel Bisulfate [O] . Dhara K. Raijada, Saranjit Singh, Arvind K. Bansal 2010
• 8. Simultaneous Estimation of Acetylsalicylic Acid and Clopidogrel Bisulfate in Pure Powder and Tablet Formulations by High-Performance Column Liquid Chromatography and High-Performance Thin-Layer Chromatography [O] . Rashmin B Patel, Madhira B Shankar, Mrunali R Patel, 2008

• 1. Analysis on the Development Trend and Countermeasures of Clopidogrel Bisulfate [J] . Wu Tong ,Dong Li . 亚洲社会药学 . 2021,第002期
• 2. Small bowel ulcer bleeding due to suspected clopidogrel use in a patient with clopidogrel resistance:A case report [J] . Sang Hoon Lee ,Dong Ryeol Ryu ,Sung Joon Lee . 世界临床病例杂志 . 2021,第015期
• 3. Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA [J] . Yongjun Wang . 四川生理科学杂志 . 2021,第8期
• 4. The efficacy and safety of clopidogrel and aspirin in coronary heart disease with angina pectoris: a systematic review and meta-analysis [J] . Chun-Ying Tian ,Yang Huang ,Xuan Sun . 亚洲毒理学研究 . 2020,第003期
• 5. 硫酸氢氯吡格雷的生物等效性及CYP2C19基因多态性对氯吡格雷代谢的影响 [C] . 杨永革 ,张梅 ,姜楠 . 第十三次全国临床药理学学术大会 . 2012
• 6. 冠脉内DES植入术后12月硫酸氢氯吡格雷减量停用与直接停用的对比研究 [A] . 钱佩瑜 . 2019